Results 1 to 10 of about 104,140 (120)

Does epidural analgesia modify the risk of complications after gastrectomy?

Nowotwory, 2021
INTRODUCTION: The surgical treatment of Gastric Cancer is associated with overall complication rates as high as 50%. The intent of this study was to assess the impact of epidural analgesia (EA) on postoperative complication rates among patients ...
Tomasz Olesiński, Marta Urbańska, Anna Borkowska, Paulina Wieszczy, Dariusz Król, Dorota Rucz, Małgorzata Symonides   +6 more
doaj   +1 more source

Evaluation of the incidence of splenic hilar lymph node metastasis in patients operated on for esophagogastric junction cancer

Nowotwory, 2023
INTRODUCTION: The purpose of this study is to evaluate the effect of esophagogastric junction cancer (EGJC) staging on the risk of splenic hilar lymph node involvement. MATERIAL AND METHODS: 312 patients with EGJC after R0 surgery were analyzed; 118 (38%)
Tomasz Olesiński, Marek Szpakowski, Wojciech Każmierczak, Urszula Sulkowska, Andrzej Rutkowski   +4 more
doaj   +1 more source

Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues

Biomedicines, 2023
Angiogenic factors (AF) promote vascular formation and may thus support neuroendocrine tumour (NET) development. This study aimed to assess AF serum level changes in NET patients treated with prolonged-acting somatostatin analogues (SSAs).
Violetta Rosiek, Ksenia Janas, Beata Kos-Kudła   +2 more
doaj   +1 more source

The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK

BMC Gastroenterology, 2020
Background NETest, a novel multi-gene liquid biopsy has utility in neuroendocrine tumor (NET) diagnosis and identification of residual disease. We independently assessed utility of the NETest to diagnose gastric neuroendocrine neoplasms (GNENs) and ...
A. Malczewska, A. Procner, A. Walter, K. Kusnierz, W. Zajecki, H. Aslanian, B. Kos-Kudla   +6 more
doaj   +1 more source

Observational Study on Antibody Response to COVID-19 Vaccines in PAtients with Gastro-Entero-PanCreatic Cancers and NeuroendocrIne NeoplAsms on Systemic TreatmEnts (VACCINATE)

Biomedicines, 2023
The coronavirus disease-19 (COVID-19) pandemic dramatically impacted oncological patients’ care. Since the introduction of vaccines and the demonstration of their benefit on frail patients, COVID-19 vaccinations were indicated to also be beneficial to ...
Alice Laffi, Lorenzo Gervaso, Oriana D’Ecclesiis, Sara Gandini, Agostino Riva, Rita Passerini, Francesca Spada, Stefania Pellicori, Manila Rubino, Chiara Alessandra Cella, Paola Simona Ravenda, Maria Giulia Zampino, Nicola Fazio   +12 more
doaj   +1 more source

Serum tumor markers for detection of bone metastases in patients with lung neuroendocrine neoplasms”

Cancer Treatment and Research Communications, 2022
Background: Bone metastases (BM) are related to worse outcome in patients with neuroendocrine neoplasms (NENpts). Aim: Assess utility of serum tumor markers (STM) for detection of BM in lung NENpts.
Violetta Rosiek, Monika Wójcik-Giertuga, Beata Kos-Kudła   +2 more
doaj   +1 more source

NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance

Endocrine Connections, 2022
Objective: Up to now, serial NETest measurements in individuals assessing the disease course of gastroenteropancreatic neuroendocrine tumors (GEPNETs) at long-term follow-up and treatment response were not studied.
Mark J C van Treijen, Catharina M Korse, Wieke H Verbeek, Margot E T Tesselaar, Gerlof D Valk   +4 more
doaj   +1 more source

The influence of surgery quality on the longtime results of gastric cancer combination therapy

Nowotwory, 2022
INTRODUCTION: The aim of this study was to analyze the influence of surgical center experience on the long term survival of patients with locoregionally advanced gastric adenocarcinoma undergoing primary surgery, followed by comple­mentary ...
Ireneusz Pierzankowski, Adam Dmitruk, Sebastian Rybski, Lucjan Wyrwicz, Tomasz Olesiński   +4 more
doaj   +1 more source

Risk of malignancy in adrenal tumors in patients with a history of cancer

Frontiers in Oncology, 2023
PurposeAdrenal gland is a common site of metastasis and on the other hand, metastases are the most frequent malignant adrenal tumors. The aim of this study was to estimate the risk of malignancy in suspicious adrenal mass in patients with a history of ...
Radosław Samsel, Karolina Nowak, Lucyna Papierska, Edyta Karpeta, Edyta Karpeta, Katarzyna Roszkowska-Purska, Wacław Smiertka, Tomasz Ostrowski, Eryk Chrapowicki, Alan Grabowski, Dorota Leszczyńska, Andrzej Cichocki   +11 more
doaj   +1 more source

Updates on medical treatment for neuroendocrine neoplasm [PDF]

Zhongguo aizheng zazhi, 2022
Neuroendocrine neoplasm (NEN) is a group of heterogeneous malignancies arising from neuroendocrine cells and peptidergic neurons. According to its cell differentiation, NEN can be divided into two distinct groups as well-differentiated neuroendocrine ...
LIANG Yun, JI Shunrong, YU Xianjun, CHEN Jie
doaj   +1 more source